Inhibitory IgG receptor FcgammaRIIB fails to inhibit experimental autoimmune myasthenia gravis pathogenesis

Journal of Neuroimmunology
Jing LiP Christadoss

Abstract

Deficiency of the inhibitory FcgammaRIIB renders mice susceptible to autoimmune disorders characterized with cellular infiltration of target tissue. To analyze the role of FcgammaRIIB in an antibody-mediated autoimmune disease, experimental autoimmune myasthenia gravis (EAMG), FcgammaRIIB knockout (KO) and wild-type mice were immunized with acetylcholine receptor (AChR). In contrast with previous reports, FcgammaRIIB KO mice were mildly resistant to EAMG despite preserved anti-AChR antibody production and neuromuscular junction complement deposition capacity. EAMG resistance was associated with reduced lymph node cell IL-6 and IL-10 production and increased CD4(+)CD25(+) cell ratios in lymph nodes. Our data suggest that FcgammaRIIB promotes antibody-mediated autoimmunity.

References

Aug 14, 1976·Lancet·P CasaliC Zanussi
Aug 30, 2001·Trends in Immunology·H M DijstelbloemC G Kallenberg
Apr 23, 2003·The American Journal of Pathology·Ruth M TarziH Terence Cook
Nov 5, 2003·Journal of Neuroimmunology·W L van der PolL H van den Berg
Aug 17, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Yi SunBao-Guo Xiao
Dec 14, 2004·Journal of Neuroimmunology·Fredrik RomiNils Erik Gilhus
Jul 6, 2005·Clinical and Experimental Immunology·Raphael ClynesHanno B Richards
Jul 15, 2005·Proceedings of the National Academy of Sciences of the United States of America·Badiga Venkata ArunaEdna Mozes
Jul 26, 2005·Immunity·Falk NimmerjahnJeffrey V Ravetch
Jan 24, 2006·Neuromuscular Disorders : NMD·Erdem TüzünPremkumar Christadoss
Sep 2, 2006·Journal of Neuroimmunology·Monica MilaniBianca M Conti-Fine
Nov 3, 2006·The Journal of Clinical Investigation·Bianca M Conti-FineHenry J Kaminski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Alternative Complement Pathway

The Alternative Complement Pathway is part of the innate immune system, and activation generates membrane attack complexes that kill pathogenic cells. Discover the latest research on the Alternative Complement Pathway.